🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Terminated
Location
UCSD Jacobs Retina Center
Start Date
2020-09-30
Trial ID
NCT04611152
Treatments Being Tested
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Completed
Location
Northwest Arkansas Retina Associates
Start Date
2020-09-25
Trial ID
NCT04592419
Treatments Being Tested
This is a Phase 1b open-label study to assess the bioactivity, ocular and s...
Status
Terminated
Location
Retinal Research Institute, LLC
Start Date
2018-12-26
Trial ID
NCT03790852
Treatments Being Tested
This Phase 3 Study will evaluate the efficacy and safety of KSI-301 in part...
Status
Terminated
Location
Retinal Research Institute, LLC
Start Date
2021-09-07
Trial ID
NCT05066230
Treatments Being Tested
This study will evaluate the efficacy, safety, durability, and pharmacokine...
Status
Terminated
Location
Retinal Research Institute, LLC
Start Date
2019-10-08
Trial ID
NCT04049266
Treatments Being Tested
This Phase 3 study will evaluate the efficacy and safety of KSI-301 compare...
Status
Completed
Location
Retinal Research Institute, LLC
Start Date
2021-06-23
Trial ID
NCT04964089
Treatments Being Tested
This study will demonstrate that tarcocimab 5 mg is superior to sham treatm...
Status
Completed
Location
Retina Associates SW
Start Date
2024-05-01
Trial ID
NCT06270836
Treatments Being Tested
This Phase 3 study will evaluate the efficacy, durability, and safety of KS...
Status
Terminated
Location
Retinal Research Institute, LLC
Start Date
2020-09-30
Trial ID
NCT04603937
Treatments Being Tested
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabi...
Status
Active Not Recruiting
Location
Associated Retina Consultants
Start Date
2024-08-23
Trial ID
NCT06556368
Treatments Being Tested